These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

217 related items for PubMed ID: 21882056

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Levetiracetam and pregabalin for antiepileptic monotherapy in patients with primary brain tumors. A phase II randomized study.
    Rossetti AO, Jeckelmann S, Novy J, Roth P, Weller M, Stupp R.
    Neuro Oncol; 2014 Apr; 16(4):584-8. PubMed ID: 24311644
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Levetiracetam vs. phenytoin as 2nd-line treatment for status epilepticus: A systematic review and meta-analysis.
    DeMott JM, Slocum GW, Gottlieb M, Peksa GD.
    Epilepsy Behav; 2020 Oct; 111():107286. PubMed ID: 32707535
    [Abstract] [Full Text] [Related]

  • 5. Intravenous levetiracetam as treatment for status epilepticus.
    Berning S, Boesebeck F, van Baalen A, Kellinghaus C.
    J Neurol; 2009 Oct; 256(10):1634-42. PubMed ID: 19458986
    [Abstract] [Full Text] [Related]

  • 6. Efficacy Of Levetiracetam Versus Phenytoin As A Second-Line Antiepileptic Drug In The Management Of Benzodiazepine-Refractory Status Epilepticus Among Children.
    Naeem B, Ashfaq M, Qureshi MA.
    J Ayub Med Coll Abbottabad; 2023 Oct; 35(3):410-414. PubMed ID: 38404082
    [Abstract] [Full Text] [Related]

  • 7. Direct and indirect comparison meta-analysis of levetiracetam versus phenytoin or valproate for convulsive status epilepticus.
    Brigo F, Bragazzi N, Nardone R, Trinka E.
    Epilepsy Behav; 2016 Nov; 64(Pt A):110-115. PubMed ID: 27736657
    [Abstract] [Full Text] [Related]

  • 8. Levetiracetam versus phenytoin in management of status epilepticus.
    Chakravarthi S, Goyal MK, Modi M, Bhalla A, Singh P.
    J Clin Neurosci; 2015 Jun; 22(6):959-63. PubMed ID: 25899652
    [Abstract] [Full Text] [Related]

  • 9. Levetiracetam in children with refractory status epilepticus.
    Gallentine WB, Hunnicutt AS, Husain AM.
    Epilepsy Behav; 2009 Jan; 14(1):215-8. PubMed ID: 18926926
    [Abstract] [Full Text] [Related]

  • 10. Intravenous levetiracetam vs phenytoin for status epilepticus and cluster seizures: A prospective, randomized study.
    Gujjar AR, Nandhagopal R, Jacob PC, Al-Hashim A, Al-Amrani K, Ganguly SS, Al-Asmi A.
    Seizure; 2017 Jul; 49():8-12. PubMed ID: 28528211
    [Abstract] [Full Text] [Related]

  • 11. Why we prefer levetiracetam over phenytoin for treatment of status epilepticus.
    Zaccara G, Giorgi FS, Amantini A, Giannasi G, Campostrini R, Giovannelli F, Paganini M, Nazerian P, Tuscany study group on seizures in the emergency department and status epilepticus in adults.
    Acta Neurol Scand; 2018 Jun; 137(6):618-622. PubMed ID: 29624640
    [Abstract] [Full Text] [Related]

  • 12. Intravenous levetiracetam: a new treatment alternative for refractory status epilepticus.
    Möddel G, Bunten S, Dobis C, Kovac S, Dogan M, Fischera M, Dziewas R, Schäbitz WR, Evers S, Happe S.
    J Neurol Neurosurg Psychiatry; 2009 Jun; 80(6):689-92. PubMed ID: 19448097
    [Abstract] [Full Text] [Related]

  • 13. Efficacy and tolerability of levetiracetam versus phenytoin after supratentorial neurosurgery.
    Milligan TA, Hurwitz S, Bromfield EB.
    Neurology; 2008 Aug 26; 71(9):665-9. PubMed ID: 18725591
    [Abstract] [Full Text] [Related]

  • 14. Efficacy of levetiracetam versus fosphenytoin for the recurrence of seizures after status epilepticus.
    Nakamura K, Inokuchi R, Daidoji H, Naraba H, Sonoo T, Hashimoto H, Tokunaga K, Hiruma T, Doi K, Morimura N.
    Medicine (Baltimore); 2017 Jun 26; 96(25):e7206. PubMed ID: 28640109
    [Abstract] [Full Text] [Related]

  • 15. Intravenous lacosamide or phenytoin for treatment of refractory status epilepticus.
    Kellinghaus C, Berning S, Stögbauer F.
    Acta Neurol Scand; 2014 May 26; 129(5):294-9. PubMed ID: 23937330
    [Abstract] [Full Text] [Related]

  • 16. Early Exposure of Fosphenytoin, Levetiracetam, and Valproic Acid After High-Dose Intravenous Administration in Young Children With Benzodiazepine-Refractory Status Epilepticus.
    Sathe AG, Mishra U, Ivaturi V, Brundage RC, Cloyd JC, Elm JJ, Chamberlain JM, Silbergleit R, Kapur J, Lowenstein DH, Shinnar S, Cock HR, Fountain NB, Babcock L, Coles LD.
    J Clin Pharmacol; 2021 Jun 26; 61(6):763-768. PubMed ID: 33336359
    [Abstract] [Full Text] [Related]

  • 17. The use of levetiracetam in refractory status epilepticus.
    Patel NC, Landan IR, Levin J, Szaflarski J, Wilner AN.
    Seizure; 2006 Apr 26; 15(3):137-41. PubMed ID: 16426869
    [Abstract] [Full Text] [Related]

  • 18. Prospective, randomized, single-blinded comparative trial of intravenous levetiracetam versus phenytoin for seizure prophylaxis.
    Szaflarski JP, Sangha KS, Lindsell CJ, Shutter LA.
    Neurocrit Care; 2010 Apr 26; 12(2):165-72. PubMed ID: 19898966
    [Abstract] [Full Text] [Related]

  • 19. Intravenous levetiracetam treatment in status epilepticus: A prospective study.
    Atmaca MM, Orhan EK, Bebek N, Gurses C.
    Epilepsy Res; 2015 Aug 26; 114():13-22. PubMed ID: 26088881
    [Abstract] [Full Text] [Related]

  • 20. Determinants of success in the use of oral levetiracetam in status epilepticus.
    Rossetti AO, Bromfield EB.
    Epilepsy Behav; 2006 May 26; 8(3):651-4. PubMed ID: 16495155
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.